Navigation Links
Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market
Date:4/22/2010

XIANYANG, China, April 22 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules ("Xin Aoxing"), and a variety of pharmaceutical products, today announced that the Company was approved by NASDAQ to list its common stock on the NASDAQ Global Market. The Company's listing application was reviewed and approved by NASDAQ's Listing Qualifications Department for compliance with all of NASDAQ's standards.

The Company's common stock will commence trading on the NASDAQ Global Market under the ticker symbol BSPM on April 23, 2010.

Announcing the listing, Chairman Mr. Ronghua Wang said, "Given Biostar's continued success and ongoing opportunities, we feel the time is right to increase our exposure to the financial markets. We believe moving to the NASDAQ Global Market will benefit our investors and is the next logical step in the Company's future growth."

About Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary in China, develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions. The Company's most popular product is its Xin Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based OTC products and two prescription-based pharmaceuticals. The Company has adopted international standards, holds one paten
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
2. Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
3. Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao
4. Renhuang Pharmaceuticals Announces Continual Improvement in Days Sales Outstanding
5. Celator(R) Pharmaceuticals Presents New Data on Two Nano-Scale Delivery Platforms at the American Association for Cancer Research
6. Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications
7. Isis Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
8. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
9. Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting
10. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results
11. Poniard Pharmaceuticals Announces $6.3 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... HILL, Conn. , July 2, 2015 ... Chief Executive Officer announced that Tamas Feitel ... Feitel joins Numotion after a highly successful 18 ... finance leadership roles driving strategy, profitability, and productivity to ... His most recent position was Chief Financial Officer for ...
(Date:7/2/2015)... and DURHAM, N.C. , July 2, ... announced its acquisition of assets related to the ion ... ) that had previously been obtained as part of ... acquired all of Pfizer,s rights to the "Icagen" name ... and will provide comprehensive services for ion channel and ...
(Date:7/2/2015)...  Konica Minolta, Inc. (Konica Minolta) ( Tokyo ... Sawae Technologica Ltda., an X-ray system equipment manufacturer based ... its Brazilian healthcare sales company, Konica Minolta Healthcare do ... Brazil market investment and growth With ... million, significant healthcare technical advancements and efficiencies are required. ...
Breaking Medicine Technology:Numotion Names Tamas Feitel Chief Financial Officer 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3
... Aesthetic Plastic,Surgery,s Annual Meeting, NEW YORK, May ... nonsurgical cosmetic enhancement are being introduced at a,rapid ... they promise? Are,the results of minimally invasive treatments, ... to more extensive procedures? Are these,new modalities safe ...
... -Memory Receives $6 Million Milestone Payment- ... at 9:00 a.m. EDT Today-, MONTVALE, N.J. and ... MEMY ) and Roche (SWX: ROG) today,announced that Roche ... Pharmaceuticals, lead nicotinic alpha-7 agonist drug,candidate, MEM 3454, for ...
Cached Medicine Technology:Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures 2Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures 3Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454 2Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454 3Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454 4
(Date:7/3/2015)... ... July 03, 2015 , ... Every year, One-to-1 Fitness and the ... members of the Red Deer community with free fitness training and indoor fitness boot ... food, events and entertainment raised thousands of charity dollars and ended with a $10,000 ...
(Date:7/2/2015)... ... ... Enterprises, LLC. is pleased to announce the opening of its newest location in Dallas, Texas. ... premium frozen yogurt chain was listed as #22 on the Inc. 500 list of fastest ... Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX 75220 , ...
(Date:7/2/2015)... ... 02, 2015 , ... The American Association of Poison Control ... Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. Together with the ... decrease drug overdose – especially of heroin and opioid medication – by expanding ...
(Date:7/2/2015)... ... ... in full swing, Americans are flocking to Canada’s many lakes to reel in their fair ... world, and it’s easy to understand why. From the Pacific Northwest Coast of British Columbia ... is a huge industry, and Americans make up the vast majority of anglers from outside ...
(Date:7/2/2015)... ... July 02, 2015 , ... As Americans celebrate the Fourth ... temps, skin cancer is on the rise. July is UV Safety Month, and physicians ... about the importance of getting skin checks. Experts say most skin cancers can be ...
Breaking Medicine News(10 mins):Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4
... PEMBROKE, Bermuda, Sept. 21 Allied World,Assurance Company Holdings, ... AVP, Risk Management for Allied World U.S., will be speaking ... Ohio Association of,Ambulatory Surgery Centers (OAASC) annual meeting at the ... Ms. McSmith,s presentation, "How Much Risk ...
... of their ability to survive too long and multiply too ... journal Experimental Hematology . To function normally, the ... divide and multiply (proliferate) and when to die. Cell death ... and billions of cells must die each year just to ...
... Scientists have ample evidence that individuals use a variety of ... resemblances in families other than their own. A new study ... whether or not those families are the same race as ... Journal of Vision ("Cross-cultural perceptions of facial resemblance ...
... INDIANAPOLIS, Sept. 21 Eli Lilly and Company ... on the Human Rights Campaign,s (HRC) Corporate Equality Index for 2010. ... the Best Places to Work for Lesbian, Gay, Bisexual, and Transgender (LGBT) ... organization,s efforts related to creating an equitable environment for lesbian, gay, bisexual, ...
... BOSTON, Sept. 21 Solos Endoscopy, Inc. (Pink Sheets: SNDY) ... new purchase orders for its MammoView(TM) line of surgical endoscopy ... their client base over the last 12 months. More than ... affiliated with prestigious public and private Universities across the Country. ...
... , , , ... Partners, LLC has discovered new prior art impacting the validity ... communications devices. Article One also announced the discovery of new ... Cymbalta to be invalid, as verified by outside counsel. The ...
Cached Medicine News:Health News:Allied World's Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 2Health News:Allied World's Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 3Health News:Experimental drug lets B cells live and lymphoma cells die 2Health News:Experimental drug lets B cells live and lymphoma cells die 3Health News:Experimental drug lets B cells live and lymphoma cells die 4Health News:Race has little effect on people's ability to spot family resemblances 2Health News:Lilly Receives 100 Percent Rating on Corporate Equality Index Survey 2Health News:Solos Endoscopy, Inc.'s MammoView(TM) Product Line Receives New Purchase Orders Primarily from Prestigious Teaching Hospitals Across the Country 2Health News:Minerva and Cymbalta Patent Invalidity Evidence Uncovered by Article One Partners Community 2Health News:Minerva and Cymbalta Patent Invalidity Evidence Uncovered by Article One Partners Community 3
Gerl titanium tying forceps has curved shanks, smooth jaws and 6 mm long tying platform. For 8-0 to 11-0 sutures....
Maumenee tying forceps is straight with concave-convex jaws and has a round handle with guide pin. For 8-0 to 11-0 sutures....
Sinskey tying forcep is very delicate with smooth jaws, curved. For 8-0 to 11-0 sutures....
Curved shafts and tips with 7 mm tying platform. Serrated handle with polished finish. Overall length 4 inches....
Medicine Products: